췌장의 선방세포악성종양

다국어 초록 (Multilingual Abstract)

Acinar cell carcinoma (ACC) is a very rare type of pancreatic cancer that makes up less than 1% of all pancreatic cancers. The prognosis of ACC is very poor and the mean survival interval is only 18-19 months. The only effective treatment is currently early radical resection.
Materials and methods: To determine ACC`s clinical characteristics and the treatment efficacy, we conducted a retrospective chart review to study the clinical characteristics, laboratory findings, pathology and treatment responses of 10 ACC patients among 3042 pancreatic cancer patients who were diagnosed in Severance Hospital and Kangnam Severance Hospital of Yonsei University, College of Medicine from 1988.01.01 to 2008.12.31.
Results: The 10 ACC patients were 6 males and 4 females. The mean age of the 10 ACC patients was 53.2 years. The most of the patients (7/10) complained the pain on the epigastric area and there was no jaundice in 8 patients (80%). Unfortunately, regional or distant metastases were founded in 8 patients (80%) at the time of the first diagnosis. The initial mean CA19-9 level was increased to 73.5 U/ml (range: 0.1~350.0 U/ml). Six of 10 patients underwent radical surgery and 4 of 10, including 1 with open and closure, were treated with conservative treatment. The median survival interval was 22.4 months with operative treatment and 1.5 months with conservative treatment. The median overall survival interval was 19.4 months. The median disease free survival was 17 months. The liver was the most common recurrent site (3 cases).
Conclusions: An early radical resection is currently the best and only treatment for ACC, but in rare cases, post-operative adjuvant chemotherapy shows hopeful results and so this requires more study.

목차 (Table of Contents)

• 서론
• 방법과 대상
• 결과
• 고찰
• 결론
• 참고문헌

참고문헌 (Reference)

1 박병규, "햄스터 췌장암 발암 과정의 기원세포로 선방세포의 역할" 대한소화기학회 41 (41): 138-144, 2003

2 김민찬, "췌장 선방세포암의 임상적 고찰 : 본원 5예와 국내 증례 보고된 5예를 중심으로" 60 (60): 97-102, 2001

3 장한정, "절제된 췌관선암의 예후 인자 및 생존율 분석" 69 : 153-6, 2005

4 BurnsWA, "and biochemical study" 33 : 1002-1009, 1974

5 Robertson JC, "Syndrome associated with pancreatic acinar cell carcinoma" 711 : 708-709, 1970

6 Hoorens A, "Pancreatic acinar cell carcinoma: An analysis of cell lineage markers, p53 expression, and Ki-ras mutations" 143 : 685-698, 1993

7 Ordonez NG, "Pancreatic acinar cell carcinoma" 8 (8): 144-159, 2001

8 Villanueva RR, "Needle aspiration cytology of acinar-cell carcinoma of the pancreas: report of a case with diagnostic pitfalls and unusual ultrastructural findings" 10 (10): 362-364, 1994

9 Chen J, "Morphological study of 391 cases of exocrine pancreatic tumors with special reference to the classification of exocrine pancreatic carcinoma" 146 : 17-29, 1985

10 Cubilla AL, "Morphological patterns of primary nonendocrine human pancreas" 35 : 2234-2238, 1975

11 Eriguchi N, "Large acinar cell carcinoma of the pancreas in a patient with elevated serum AFP level" 7 (7): 222-225, 2000

12 Basturk O, "Intraductal and Papillary Variants of Acinar Cell Carcinomas: A New Addition to the Challenging Differential Diagnosis of Intraductal Neoplasms" 31 : 363-370, 2007

13 Fabre A, "Intraductal acinar cell carcinoma of the pancreas" 438 (438): 312-315, 2001

14 Samuel LH, "Fine needle aspiration cytology of acinar cell carcinoma of the pancreas: a report of two cases" 40 (40): 585-591, 1996

15 Holen KD, "Clinical characteristics and outcomes from an institutional series of acinar cell carcinoma of the pancreas and related tumors" 20 : 4673-4678, 2002

16 Tatli S, "CT and MRI features of pure acinar cell carcinoma of the pancreas in adults" 184 (184): 511-519, 2005

17 Pasquali C, "CA 50 compared with CA 19-9 as a serum tumor marker for pancreatic carcinoma" 26 (26): 169-173, 1994

18 Cingolani N, "Alpha-fetoprotein production by pancreatic tumors exhibiting acinar cell differentiation: study of five cases, one arising in a mediastinal teratoma" 31 (31): 938-944, 2000

19 Colombo P, "Acinar cell cystadenocarcinoma of the pancreas: report of rare case and review of the literature" 35 (35): 1568-1571, 2004

20 Chiou YY, "Acinar cell carcinoma of the pancreas: clinical and computed tomography manifestations" 28 (28): 180-186, 2004

21 Kuopio T, "Acinar cell carcinoma of the pancreas: Report of three cases" 103 : 69-78, 1995

22 Klimstra DS, "Acinar cell carcinoma of the pancreas: A clinicopathologic study of 28 cases" 16 : 815-837, 1992

23 Caruso RA, "Acinar cell carcinoma of the pancreas. A histologic, immunocytochemical and ultrastructural study" 9 : 53-58, 1994

24 MacMahon HE, "Acinar cell carcinoma of the pancreas with subcutaneous fat necrosis" 49 : 555-559, 1965

25 Itoh T, "Acinar cell carcinoma of the pancreas with elevated serum alphafetoprotein levels: A case report and a review of 28 cases reported in Japan" 27 (27): 785-791, 1992

26 Ordonez NG, "Acinar cell carcinoma of the pancreas" 24 : 227-41, 2000

27 Sun Y, "Acinar cell carcinoma arising in the stomach: a case report with literature review" 35 (35): 263-265, 2004

28 Seth AK, "Acinar Cell Carcinoma of the Pancreas: An Institutional Series of Resected Patients and Review of the Current Literature" 12 : 1061-1067, 2008

29 "2007 annual report of the Korea central cancer registry: Korea central cancer registry ministry of health and welfare" Republic of Korea